Clinical Trial Update: Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing melphalan with versus without tumor necrosis factor for locally advanced melanoma of the arm or leg has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Melphalan (Melphalan)
• Tumor necrosis factor (tumor necrosis factor)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage III Melanoma | Phase 3 | Status: COMPLETED